WARD Surgical RCT

WARD Surgical RCT

Principal Investigator

Jesper Mølgaard, MD, PhD student

Study design
Randomized controlled trial
Sample size
400 participants
Study sites

Rigshospitalet and Bispebjerg Hospital

Inclusion criteria
  • Admission for acute or elective major abdominal (laparotomy/laparoscopy), major orthopedic, major urologic, or arterial vascular surgery.
  • Estimated duration of surgery ≥2 hours and at least two expected overnight stays.
  • Randomization and commencement of continuous wireless monitoring possible within 24 hours postoperatively
Study procedures

Four hundred patients were randomly assigned to usual care plus continuous monitoring with smartphone alerts to staff, or usual care with the research monitoring concealed. Monitoring continued on the surgical ward after surgery. Researchers assessed complications within 30 days.

Results

Four hundred patients were randomized, with 200 in the intervention and 200 in the control group, respectively. Median [interquartile range (IQR)] duration of severely deviating vital signs was 60 [25-136] vs 76 [28-192] min/d in the intervention versus control group, respectively ( P = .19). Duration of Sp o2 <88% had a mean reduction of 47 minutes per day (95% confidence interval [CI], 18-80, P = .02). Adverse events occurred in 42.5% vs 31.5% of patients within 30 days ( P = .02), and serious adverse events in 34.5% vs 29.5% ( P = .39).

Outcome

The primary outcome is the amount and duration of physiological parameter deviations between the two groups. Secondary outcome is the number of postoperative complications within 30 days after surgery between the two groups.

Trial registration
NCT04640415

–  Read more